Page last updated: 2024-10-26

dipyridamole and Cranial Sinus Thrombosis

dipyridamole has been researched along with Cranial Sinus Thrombosis in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"The treatment with dipyridamole, aspirin and a nicotinic acid derivative was followed by good results."1.26Further studies on clotting changes in patients with cerebral sinus thrombosis. A case with thrombosis of right transverse sinus. ( Gerosa, M; Girolami, A; Patrassi, G; Rotilio, A, 1981)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Girolami, A1
Rotilio, A1
Gerosa, M1
Patrassi, G1

Other Studies

1 other study available for dipyridamole and Cranial Sinus Thrombosis

ArticleYear
Further studies on clotting changes in patients with cerebral sinus thrombosis. A case with thrombosis of right transverse sinus.
    Folia haematologica (Leipzig, Germany : 1928), 1981, Volume: 108, Issue:4

    Topics: Adult; Dipyridamole; Female; Fibrinolysis; Humans; Niacin; Nicotinic Acids; Ophthalmoscopy; Platelet

1981